David A. Siegel Sutro Biopharma, Inc. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 671,100 shares of STRO stock, worth $1.97 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
671,100
Previous 239,800
179.86%
Holding current value
$1.97 Million
Previous $1.03 Million
268.77%
% of portfolio
0.01%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding STRO
# of Institutions
122Shares Held
53.3MCall Options Held
7.8KPut Options Held
2.4K-
Suvretta Capital Management, LLC New York, NY5.78MShares$16.9 Million1.4% of portfolio
-
Black Rock Inc. New York, NY5.7MShares$16.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.74MShares$13.9 Million0.01% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.1MShares$12 Million3.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.02MShares$8.86 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $153M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...